Search

Royalty Pharma PLC (Class A)

Отворен

СекторЗдравеопазване

60.24 -1.18

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

59.97

Максимум

61.09

Ключови измерители

By Trading Economics

Приходи

-589M

-295M

Продажби

44M

674M

P/E

Средно за сектора

31.232

48.735

EPS

1.32

Дивидентна доходност

1.6

Марж на печалбата

-43.713

Служители

100

EBITDA

-387M

176M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+8.27% upside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

1.60%

2.24%

Следващи печалби

4.11.2026 г.

Следваща дата на дивидент

10.12.2026 г.

Следваща дата на екс-дивидент

13.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

467M

33B

Предишно отваряне

61.42

Предишно затваряне

60.24

Royalty Pharma PLC (Class A) Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.10.2026 г., 20:02 ч. UTC

News

Royalty Pharma PLC declared a quarterly dividend of $0.235 per Class A share, payable on December 10, 2026, to shareholders of record as of November 13, 2026.

15.10.2026 г., 20:07 ч. UTC

Correlated Moves

Royalty Pharma PLC shares advanced, supported by broader market strength, while the Health Care Select Sector SPDR ETF reached a record high.

14.10.2026 г., 20:02 ч. UTC

Royalty Pharma PLC is advancing during Wednesday's market hours, continuing its upward trajectory since Tuesday's close with unusually high trading volume.

13.10.2026 г., 20:02 ч. UTC

Royalty Pharma PLC shares fell sharply, trading near the low end of their one-month range after an initial rebound earlier in the session.

12.10.2026 г., 20:06 ч. UTC

Royalty Pharma PLC is advancing, reflecting a strong performance since Friday's close, with today's price peaking in the early afternoon before settling slightly lower.

9.10.2026 г., 21:01 ч. UTC

Royalty Pharma PLC shares traded lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

8.10.2026 г., 20:13 ч. UTC

Royalty Pharma PLC shares advanced modestly during after-market hours on Thursday, holding steady with no notable fluctuations since the market closed.

7.10.2026 г., 19:35 ч. UTC

News

Royalty Pharma PLC shares advanced modestly after Morgan Stanley raised its price target to $67.00 from $65.00 while maintaining an Overweight rating.

6.10.2026 г., 20:12 ч. UTC

Royalty Pharma PLC is trading modestly higher in after-market hours, maintaining a steady position below its 20-day moving average and near the lower end of its one-month range.

5.10.2026 г., 20:02 ч. UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend amid broader pharmaceutical sector weakness and reflecting unusually high market volume.

2.10.2026 г., 20:07 ч. UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend and hitting a session low just before market close, significantly below its 20-day moving average.

1.10.2026 г., 20:07 ч. UTC

Royalty Pharma PLC shares fell sharply, remaining below their 20-day moving average and positioned near the lower end of their one-month range.

30.09.2026 г., 20:20 ч. UTC

Royalty Pharma PLC gained in after-market trading, recovering from a slight loss and marking a significant shift near the lower end of its one-month trading range.

29.09.2026 г., 20:07 ч. UTC

Royalty Pharma PLC shares fell modestly, continuing a decline from Monday's close, amid a broader market dip and positioning below the 20-day moving average.

28.09.2026 г., 22:06 ч. UTC

Royalty Pharma PLC traded modestly higher in after-market hours, maintaining a stable performance despite being below its 20-day moving average.

24.09.2026 г., 19:25 ч. UTC

Royalty Pharma PLC shares are rising, reflecting notable market strength, although they remain below the 20-day moving average and near the one-month range's lower end.

23.09.2026 г., 19:51 ч. UTC

Royalty Pharma PLC shares fell sharply, reaching a session low just before 1 PM, as the broader market declines and remains below its 20-day moving average.

22.09.2026 г., 20:06 ч. UTC

Correlated Moves

Royalty Pharma PLC is trading higher, likely influenced by Amgen Inc.'s positive Phase 3 OASIZ 301 study results, despite earlier pulling back from a session high.

21.09.2026 г., 20:06 ч. UTC

Royalty Pharma PLC's shares are trading roughly flat, remaining below the 20-day moving average and near the lower end of their one-month range.

18.09.2026 г., 20:06 ч. UTC

Royalty Pharma PLC shares fell sharply on Friday, closing significantly below its 20-day moving average and near the lower end of its one-month range.

17.09.2026 г., 23:06 ч. UTC

Royalty Pharma PLC declined in after-market trading, moving lower since Thursday's close and positioning it below its 20-day moving average.

16.09.2026 г., 23:06 ч. UTC

Royalty Pharma PLC is trading lower in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15.09.2026 г., 23:16 ч. UTC

News

Royalty Pharma announced a $7.5 million donation to Blood Cancer United. Shares are lower in after-market trading amid rising Treasury yields.

14.09.2026 г., 20:07 ч. UTC

Royalty Pharma PLC shares are higher today, reflecting a modest gain since Friday. Broader market concerns over rising crude oil prices may be influencing sentiment.

11.09.2026 г., 20:08 ч. UTC

Royalty Pharma PLC shares are lower today, pulling back from earlier gains amid broader market dynamics and inflation pressures influencing Federal Reserve policy.

10.09.2026 г., 23:46 ч. UTC

Royalty Pharma PLC shares are higher in after-market trading, continuing a rise since Thursday's close, though still below the 20-day moving average.

9.09.2026 г., 20:07 ч. UTC

News

Royalty Pharma shares lower today, following a decline after Novartis' trial failure. Analysts suggest the drop may be overdone amid stable royalty expectations.

8.09.2026 г., 21:01 ч. UTC

Royalty Pharma PLC shares are higher in after-market hours, reflecting broader market dynamics despite no specific company news identified.

5.09.2026 г., 00:01 ч. UTC

News

Royalty Pharma PLC shares fell in after-market hours following the failed Phase 3 trial of pelacarsen, impacting its funding agreement with Ionis.

4.09.2026 г., 22:14 ч. UTC

Royalty Pharma PLC shares are trading lower during after-market hours, breaking a trend of higher daily closes. No specific news was identified for the decline.

Сравнение с други в отрасъла

Ценова промяна

Royalty Pharma PLC (Class A) Прогноза

Ценова цел

By TipRanks

8.27% нагоре

12-месечна прогноза

Среден 66 USD  8.27%

Висок 70 USD

Нисък 62 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Royalty Pharma PLC (Class A) през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

7 ratings

7

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Royalty Pharma PLC (Class A)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
help-icon Live chat